Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020
Stock Information for Acasti Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.